FDA inspection
UCB Pharma S.A.: FDA inspection ending Jun 4, 2026
FDA inspection 1323186 · Voluntary Action Indicated (VAI) · Braine-L'Alleud
Key facts
| Inspection ID | 1323186 |
|---|---|
| Firm | UCB Pharma S.A. |
| FEI number | 3003909356 |
| Address | Chemin Du Foriest |
| City | Braine-L'Alleud |
| Country | Belgium |
| Fiscal year | 2026 |
| Inspection end date | Jun 4, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data